Wan Xinlong, Shi Xuan, Li Mengke, Chen Qing, Xue Chang, Li Guanghui, Huang Yeke, Yang Jingwen, Chen Chan, Wang Zhiyi, Ma Shumei, Liu Xiaodong
South ZheJiang Institute of Radiation Medicine and Nuclear Technology, Wenzhou Medical University, China.
School of Public Health and Management, Wenzhou Medical University, China.
Dose Response. 2022 Jun 7;20(2):15593258221107193. doi: 10.1177/15593258221107193. eCollection 2022 Apr-Jun.
Radiation-induced lung injuries (RILI) is one of the serious complications of radiotherapy posed by the damage of alveolar cells and inflammation over-reaction. We aimed to investigate the potential protective effects of doxepin on RILI (20 Gy total dose at 3 Gy/min of X-ray irradiation), as well as its underlying mechanism. For animal experiments, such parameters as Immunohistochemistry and hematoxylin and eosin (H&E) staining, WBC (white blood cell), CRP (C-reactive protein), Western blot, and q-PCR were detected. The results indicated that both survival status and weight increase of irradiated rats treated by doxepin (3 mg/kg/day, rat) were higher than those of treated with irradiation alone (Dosing started the day before irradiation). Further, histological examinations showed doxepin could tenuate the radiation injury, as indicated as alveolar inflammatory exudation and there was only mild interstitial inflammation infiltration. Western blotting and q-PCR showed that expression of NF-κβ in X group were higher than that in XMD group. For the first time, we reported doxepin functioned as a radioprotectant candidate, which provide a promising application of doxepin for protecting radiotherapy injuries.
放射性肺损伤(RILI)是放疗的严重并发症之一,由肺泡细胞损伤和炎症过度反应引起。我们旨在研究多塞平对RILI(X射线照射总剂量20 Gy,剂量率3 Gy/min)的潜在保护作用及其潜在机制。在动物实验中,检测了免疫组织化学、苏木精-伊红(H&E)染色、白细胞(WBC)、C反应蛋白(CRP)、蛋白质免疫印迹法和定量聚合酶链反应(q-PCR)等参数。结果表明,多塞平(3 mg/kg/天,大鼠)治疗的受照射大鼠的生存状态和体重增加均高于单纯照射治疗的大鼠(给药在照射前一天开始)。此外,组织学检查显示多塞平可减轻辐射损伤,表现为肺泡炎性渗出,仅有轻度间质炎症浸润。蛋白质免疫印迹法和q-PCR显示,X组中核因子κB(NF-κβ)的表达高于多塞平组(XMD组)。我们首次报道多塞平可作为一种辐射防护剂候选物,这为多塞平在保护放疗损伤方面提供了有前景的应用。